Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma

BackgroundThe prevalence of thyroid carcinoma (TC) and Hashimoto’s thyroiditis (HT) has been increasing dramatically over the past decades. We investigated the relationship between HT and TC.MethodsWe followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines for carrying...

Full description

Bibliographic Details
Main Authors: Jiangyue Xu, Ke Ding, Lan Mu, Jiangsheng Huang, Fei Ye, Yu Peng, Can Guo, Chutong Ren
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.801925/full
_version_ 1819279408836378624
author Jiangyue Xu
Ke Ding
Lan Mu
Jiangsheng Huang
Fei Ye
Yu Peng
Can Guo
Chutong Ren
author_facet Jiangyue Xu
Ke Ding
Lan Mu
Jiangsheng Huang
Fei Ye
Yu Peng
Can Guo
Chutong Ren
author_sort Jiangyue Xu
collection DOAJ
description BackgroundThe prevalence of thyroid carcinoma (TC) and Hashimoto’s thyroiditis (HT) has been increasing dramatically over the past decades. We investigated the relationship between HT and TC.MethodsWe followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines for carrying out and reporting this meta-analysis. The literature from January 1, 2010 to December 31, 2020, regardless of region and publication type, was searched comprehensively in PubMed, Embase, Web of Science, and Cochrane Library databases. After careful selection and data extraction, the pooled odds ratio of various clinical characteristics in 39 studies were calculated. Publication bias was analyzed using funnel plots.ResultsMeta-analysis of 39 original research articles showed HT to be a risk factor of TC (pooled odds ratio = 1.71; 95% confidence interval, 1.57–1.80; p < 0.00001) and papillary thyroid carcinoma (1.67, 1.51–1.85, <0.00001). Patients with papillary thyroid carcinoma (PTC) combined with HT were more likely to have multifocal carcinomas. The prevalence of an extrathyroidal extension, metastasis, BRAFV600E mutation, and recurrence was significantly lower in patients with PTC combined with HT.ConclusionsHT is a “double-edged sword” in TC patients. HT increases the risk of TC and PTC but is a protective factor against PTC progression.
first_indexed 2024-12-24T00:27:26Z
format Article
id doaj.art-9a3aa21bfdaf449a82e11f661683b2b1
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-24T00:27:26Z
publishDate 2022-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-9a3aa21bfdaf449a82e11f661683b2b12022-12-21T17:24:24ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-02-011310.3389/fendo.2022.801925801925Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid CarcinomaJiangyue Xu0Ke Ding1Lan Mu2Jiangsheng Huang3Fei Ye4Yu Peng5Can Guo6Chutong Ren7Department of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of General Surgery Thyroid Specialty, The Second Xiangya Hospital of Central South University, Changsha, ChinaBackgroundThe prevalence of thyroid carcinoma (TC) and Hashimoto’s thyroiditis (HT) has been increasing dramatically over the past decades. We investigated the relationship between HT and TC.MethodsWe followed the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines for carrying out and reporting this meta-analysis. The literature from January 1, 2010 to December 31, 2020, regardless of region and publication type, was searched comprehensively in PubMed, Embase, Web of Science, and Cochrane Library databases. After careful selection and data extraction, the pooled odds ratio of various clinical characteristics in 39 studies were calculated. Publication bias was analyzed using funnel plots.ResultsMeta-analysis of 39 original research articles showed HT to be a risk factor of TC (pooled odds ratio = 1.71; 95% confidence interval, 1.57–1.80; p < 0.00001) and papillary thyroid carcinoma (1.67, 1.51–1.85, <0.00001). Patients with papillary thyroid carcinoma (PTC) combined with HT were more likely to have multifocal carcinomas. The prevalence of an extrathyroidal extension, metastasis, BRAFV600E mutation, and recurrence was significantly lower in patients with PTC combined with HT.ConclusionsHT is a “double-edged sword” in TC patients. HT increases the risk of TC and PTC but is a protective factor against PTC progression.https://www.frontiersin.org/articles/10.3389/fendo.2022.801925/fullHashimoto’s thyroiditis (HT)thyroid carcinoma (TC)meta-analysispapillary thyroid carcinomaBRAFV600E mutation
spellingShingle Jiangyue Xu
Ke Ding
Lan Mu
Jiangsheng Huang
Fei Ye
Yu Peng
Can Guo
Chutong Ren
Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
Frontiers in Endocrinology
Hashimoto’s thyroiditis (HT)
thyroid carcinoma (TC)
meta-analysis
papillary thyroid carcinoma
BRAFV600E mutation
title Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
title_full Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
title_fullStr Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
title_full_unstemmed Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
title_short Hashimoto’s Thyroiditis: A “Double-Edged Sword” in Thyroid Carcinoma
title_sort hashimoto s thyroiditis a double edged sword in thyroid carcinoma
topic Hashimoto’s thyroiditis (HT)
thyroid carcinoma (TC)
meta-analysis
papillary thyroid carcinoma
BRAFV600E mutation
url https://www.frontiersin.org/articles/10.3389/fendo.2022.801925/full
work_keys_str_mv AT jiangyuexu hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT keding hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT lanmu hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT jiangshenghuang hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT feiye hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT yupeng hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT canguo hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma
AT chutongren hashimotosthyroiditisadoubleedgedswordinthyroidcarcinoma